IN2014CN04693A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04693A IN2014CN04693A IN4693CHN2014A IN2014CN04693A IN 2014CN04693 A IN2014CN04693 A IN 2014CN04693A IN 4693CHN2014 A IN4693CHN2014 A IN 4693CHN2014A IN 2014CN04693 A IN2014CN04693 A IN 2014CN04693A
- Authority
- IN
- India
- Prior art keywords
- scymnol
- ester
- patient
- seborrhoea
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011905331A AU2011905331A0 (en) | 2011-12-20 | Treatment of seborrhoea | |
| AU2012900670A AU2012900670A0 (en) | 2012-02-22 | Treatment of seborrhoea | |
| PCT/AU2012/001543 WO2013090986A1 (en) | 2011-12-20 | 2012-12-14 | Treatment of seborrhoea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04693A true IN2014CN04693A (ru) | 2015-09-18 |
Family
ID=48667492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4693CHN2014 IN2014CN04693A (ru) | 2011-12-20 | 2012-12-14 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20140364405A1 (ru) |
| EP (1) | EP2793897B1 (ru) |
| JP (1) | JP2015500841A (ru) |
| KR (1) | KR20140120890A (ru) |
| CN (1) | CN104144689A (ru) |
| AU (1) | AU2012321108B2 (ru) |
| BR (1) | BR112014014968A2 (ru) |
| CA (1) | CA2859826A1 (ru) |
| DK (1) | DK2793897T3 (ru) |
| ES (1) | ES2632591T3 (ru) |
| HK (1) | HK1199818A1 (ru) |
| HU (1) | HUE033800T2 (ru) |
| IN (1) | IN2014CN04693A (ru) |
| MX (1) | MX2014007659A (ru) |
| MY (1) | MY165030A (ru) |
| PL (1) | PL2793897T3 (ru) |
| PT (1) | PT2793897T (ru) |
| RU (1) | RU2624238C2 (ru) |
| SG (1) | SG11201403078RA (ru) |
| WO (1) | WO2013090986A1 (ru) |
| ZA (1) | ZA201404348B (ru) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA876171B (en) * | 1986-08-21 | 1988-10-26 | Broadbent James Meredyth | Active principle isolated from shark tissue |
| ZA947912B (en) * | 1993-10-12 | 1995-05-24 | Broadbent J W Nominees Pty Ltd | Treatment of medical disorders associated with free radical formation |
| JP2007063139A (ja) * | 2005-08-29 | 2007-03-15 | Daicho Kikaku:Kk | 皮膚用剤 |
| JP2007244325A (ja) * | 2006-03-17 | 2007-09-27 | Daicho Kikaku:Kk | 新しい健康食品 |
-
2012
- 2012-12-14 KR KR1020147020089A patent/KR20140120890A/ko not_active Application Discontinuation
- 2012-12-14 CA CA2859826A patent/CA2859826A1/en not_active Abandoned
- 2012-12-14 PL PL12859788T patent/PL2793897T3/pl unknown
- 2012-12-14 US US14/366,261 patent/US20140364405A1/en not_active Abandoned
- 2012-12-14 JP JP2014547630A patent/JP2015500841A/ja active Pending
- 2012-12-14 RU RU2014126635A patent/RU2624238C2/ru active
- 2012-12-14 IN IN4693CHN2014 patent/IN2014CN04693A/en unknown
- 2012-12-14 SG SG11201403078RA patent/SG11201403078RA/en unknown
- 2012-12-14 MY MYPI2014001674A patent/MY165030A/en unknown
- 2012-12-14 WO PCT/AU2012/001543 patent/WO2013090986A1/en active Application Filing
- 2012-12-14 EP EP12859788.7A patent/EP2793897B1/en active Active
- 2012-12-14 BR BR112014014968A patent/BR112014014968A2/pt not_active Application Discontinuation
- 2012-12-14 CN CN201280063798.3A patent/CN104144689A/zh active Pending
- 2012-12-14 ES ES12859788.7T patent/ES2632591T3/es active Active
- 2012-12-14 PT PT128597887T patent/PT2793897T/pt unknown
- 2012-12-14 AU AU2012321108A patent/AU2012321108B2/en active Active
- 2012-12-14 DK DK12859788.7T patent/DK2793897T3/en active
- 2012-12-14 HU HUE12859788A patent/HUE033800T2/en unknown
- 2012-12-14 MX MX2014007659A patent/MX2014007659A/es unknown
-
2014
- 2014-06-12 ZA ZA2014/04348A patent/ZA201404348B/en unknown
-
2015
- 2015-01-12 HK HK15100268.8A patent/HK1199818A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013090986A1 (en) | 2013-06-27 |
| PL2793897T3 (pl) | 2017-10-31 |
| RU2624238C2 (ru) | 2017-07-03 |
| PT2793897T (pt) | 2017-07-17 |
| EP2793897A4 (en) | 2015-04-08 |
| CN104144689A (zh) | 2014-11-12 |
| HUE033800T2 (en) | 2018-01-29 |
| SG11201403078RA (en) | 2014-07-30 |
| BR112014014968A2 (pt) | 2017-06-13 |
| RU2014126635A (ru) | 2016-02-10 |
| NZ625852A (en) | 2015-07-31 |
| ES2632591T3 (es) | 2017-09-14 |
| AU2012321108B2 (en) | 2015-07-09 |
| MX2014007659A (es) | 2014-11-14 |
| CA2859826A1 (en) | 2013-06-27 |
| US20140364405A1 (en) | 2014-12-11 |
| ZA201404348B (en) | 2016-10-26 |
| EP2793897B1 (en) | 2017-04-12 |
| KR20140120890A (ko) | 2014-10-14 |
| MY165030A (en) | 2018-02-28 |
| DK2793897T3 (en) | 2017-07-31 |
| EP2793897A1 (en) | 2014-10-29 |
| HK1199818A1 (en) | 2015-07-24 |
| JP2015500841A (ja) | 2015-01-08 |
| AU2012321108A1 (en) | 2013-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2747680A4 (en) | SYSTEMS, DEVICES AND METHODS FOR LUMINAL TISSUE PROCESSING | |
| EP2726066A4 (en) | DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME | |
| UA115139C2 (uk) | Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| EP2689860A4 (en) | ENVIRONMENTALLY FRIENDLY EASY-TREATMENT DEVICE | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| IN2014CN04634A (ru) | ||
| MX350666B (es) | Composiciones y sus usos para tratar hiperuricemia y trastornos metabolicos asociados con hiperuricemia. | |
| WO2012071369A3 (en) | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease | |
| MX2012007875A (es) | Uso de derivados de 5-[[2, 3-dimetil-2h-indazol-6-il)-metilamino]- 2-pirimidil] amino]-2-metilbencensulfonamida en transtornos oculares. | |
| PH12014500990A1 (en) | Methods for treating gout flares | |
| MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
| MY195767A (en) | Treatment of Androgen Deprivation Therapy Associated Symptoms | |
| MX352788B (es) | La mirra en forma de dosificación vaginal para su uso en el tratamiento de la atrofia vaginal como síntoma menopáusico. | |
| WO2012112862A3 (en) | Treating mycobacterial infection with cu+/++ boosting therapeutics | |
| IN2014CN04693A (ru) | ||
| MX2014003867A (es) | Tratamiento de rinitis. | |
| WO2013015634A3 (en) | Pharmaceutical composition for treating atopic dermatitis | |
| UA65038U (ru) | Способ лечения больных послеродовыми психозами | |
| UA52204U (ru) | Способ катетерной интраоперационной склеротерапии при лечении варикозной болезни | |
| UA60148U (ru) | Способ лечения больных неалкогольным стеатогепатитом | |
| UA59700U (ru) | Способ лечения метаболического синдрома | |
| UA55818U (ru) | Способ лечения хронических заболеваний роговицы | |
| UA58758U (ru) | Способ коррекции иммунного статуса больных с неалкогольным стеатогепатитом | |
| UA53280U (ru) | Способ лечения больных стабильной стенокардией напряжения |